Functional studies of a germ-line polymorphism at codon 47 within the p53 gene
- PMID: 8352280
- PMCID: PMC1682404
Functional studies of a germ-line polymorphism at codon 47 within the p53 gene
Abstract
A rare germ-line polymorphism in codon 47 of the p53 gene replaces the wild-type proline (CCG) with a serine (TCG). Restriction analysis of 101 human samples revealed the frequency of the rare allele to be 0% (n = 69) in Caucasians and 4.7% (3/64, n = 32) among African-Americans. To investigate the consequence of this amino acid substitution, a cDNA construct (p53 mut47ser) containing the mutation was introduced into a lung adenocarcinoma cell line (Calu-6) that does not express p53. A growth suppression similar to that obtained after introduction of a wild-type p53 cDNA construct was observed, in contrast to the result obtained by introduction of p53 mut143ala. Furthermore, expression of neither p53 mut47ser nor wild-type p53 was tolerated by growing cells. In transient expression assays, both mut47ser and wild-type p53 activated the expression of a reporter gene linked to a p53 binding sequence (PG13-CAT) and inhibited the expression of the luciferase gene under the control of the Rous sarcoma virus promoter (RSVluc). In the same assay, mut143ala did not activate the expression of PG13-CAT and produced only a slight inhibitory effect on RSVluc. These findings indicate that the p53 variant with a serine at codon 47 should be considered as a rare germ-line polymorphism that does not alter the growth-suppression activity of p53.
Similar articles
-
The codon 47 polymorphism in p53 is functionally significant.J Biol Chem. 2005 Jun 24;280(25):24245-51. doi: 10.1074/jbc.M414637200. Epub 2005 Apr 25. J Biol Chem. 2005. PMID: 15851479
-
Allelic frequency of a p53 polymorphism in human lung cancer.Cancer Epidemiol Biomarkers Prev. 1992 Sep-Oct;1(6):481-3. Cancer Epidemiol Biomarkers Prev. 1992. PMID: 1302561
-
Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis.Environ Health Perspect. 1992 Nov;98:61-7. doi: 10.1289/ehp.929861. Environ Health Perspect. 1992. PMID: 1486864 Free PMC article.
-
No point mutation but a codon 31ser-->arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese.Cancer Epidemiol Biomarkers Prev. 1995 Apr-May;4(3):261-7. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 7606201
-
Mutations of the p53 gene in human functional adrenal neoplasms.J Clin Endocrinol Metab. 1994 Feb;78(2):483-91. doi: 10.1210/jcem.78.2.8106638. J Clin Endocrinol Metab. 1994. PMID: 8106638
Cited by
-
TP53 genetic polymorphisms and susceptibility to cervical cancer in Bangladeshi women: a case-control study.Mol Biol Rep. 2020 Jun;47(6):4357-4364. doi: 10.1007/s11033-020-05523-2. Epub 2020 May 18. Mol Biol Rep. 2020. PMID: 32424519
-
Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma.Clin Cancer Res. 2009 Apr 1;15(7):2406-16. doi: 10.1158/1078-0432.CCR-08-1719. Clin Cancer Res. 2009. PMID: 19339276 Free PMC article.
-
TP53 polymorphism may contribute to genetic susceptibility to develop Hashimoto's thyroiditis.J Endocrinol Invest. 2015 Nov;38(11):1175-82. doi: 10.1007/s40618-015-0292-9. Epub 2015 May 3. J Endocrinol Invest. 2015. PMID: 25935255
-
Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.Tumour Biol. 2014 Oct;35(10):10309-17. doi: 10.1007/s13277-014-2285-2. Epub 2014 Jul 18. Tumour Biol. 2014. PMID: 25034526
-
Genetic Modifiers of the p53 Pathway.Cold Spring Harb Perspect Med. 2016 Apr 1;6(4):a026302. doi: 10.1101/cshperspect.a026302. Cold Spring Harb Perspect Med. 2016. PMID: 27037420 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous